โœ‰  info@marketresearchfuture.com   ๐Ÿ“ž +1 (855) 661-4441(US)   ๐Ÿ“ž +44 1720 412 167(UK)   ๐Ÿ“ž +91 2269738890(APAC)
Certified Global Research Member
Isomar 1 Iso 1
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major playersรขโ‚ฌโ„ข financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Non-Sterile Compounding Pharmacy Companies

U.S. and Europe Non-Sterile Compounding pharmacies specialize in the preparation of medications that do not require a sterile environment. These pharmacies play a crucial role in providing customized medications tailored to the specific needs of patients.

Top Industry Leaders in the Non-Sterile Compounding Pharmacy Market

US and Europe Non-Sterile Compounding Pharmacy Key CompaniesLatest U.S. and Europe Non-Sterile Compounding Pharmacy Companies Update



  • June 2023: two major industry players, BCE Pharma and PCCA, announced a cooperation to raise the bar for compounding pharmacies in Canada. Together, they will provide pharmacies in Canada third-party review services and cutting-edge technological resources for adhering to and exceeding all applicable pharmacy practice requirements. Canadian pharmacies will be given the tools they need to become compliant with regulations thanks to PCCA's partnership with BCE Pharma. Together, we can improve the quality, efficiency, and uniformity of sterile and non-sterile chemical preparation in pharmacies. Training will be provided by PCCA and BCE Pharma and will include rigorous evaluation procedures and be overseen by a staff of highly trained professionals.




  • June 2022: Osceola Capital, a lower middle-market private-equity company, revealed that it had acquired Wedgewood Pharmacy's human-health book of business, making it the ninth addition to the Revelation Pharma Corporation platform. Wedgewood Pharmacy runs compounding pharmacies in all 50 states, providing pet owners with sterile and non-sterile compounded pharmaceuticals. The details of the deal were kept confidential. The purchase of Wedgewood Pharmacy's book of business underscores Revelation's continuous aim to acquire and build a nationwide partnership of 503A and 503B compounding pharmacies and Wedgewood Pharmacy's strategy to focus on compounding exclusively for animal health in its compounding pharmacies. When mass-produced pharmaceuticals are either not accessible or not suited for a patient, compounded medications are developed and made by properly educated pharmacists and pharmacy technicians in pharmacies governed by the state.


List of U.S. and Europe Non-Sterile Compounding Pharmacy Key companies in the market

  • Fagron (the Netherlands)

  • B.Braun Melsungen AG (Germany)

  • Fresenius Kabi AG (Germany)

  • TRUE NATURE HOLDING, INC (U.S)

  • Dougherty's Pharmacy Inc. (U.S.)

  • PHARMEDIUM (U.S.)

Leading companies partner with us for data-driven Insights
clients
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.